Brand names
Atoltivimab, Maftivimab and Odesivimab brand names
1 brands in 1 markets
Atoltivimab, Maftivimab and Odesivimab is sold under 1 brand names in 1 markets in our register data, including Inmazeb. The table shows the market, marketing authorisation holder, strengths and forms for each brand, with the register it comes from.
| Brand | Market | Marketing authorisation holder | Strengths and forms | Source |
|---|---|---|---|---|
| Inmazeb | United States | Regeneron Pharmaceuticals | 241.7 mg/241.7 mg/241.7 mg per 14.5 mL, 483.3 mg/483.3 mg/483.3 mg per 14.5 mLInjection | US FDA NDC directoryChecked 12 November 2026 |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Atoltivimab, Maftivimab and Odesivimab for export supply
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.